Phase I clinical trial of marizomib (NPI-0052) in patients with advanced malignancies including multiple myeloma: study NPI-0052-102 final results

…, P Mainwaring, T Price, MJ Millward, P Padrik… - Clinical Cancer …, 2016 - AACR
Purpose: Marizomib (NPI-0052) is an irreversible proteasome inhibitor, derived from a marine
actinomycete, with activity and specificity that is distinct from other proteasome inhibitors. …

[HTML][HTML] Identification of bull semen microbiome by 16S sequencing and possible relationships with fertility

A Cojkic, A Niazi, Y Guo, T Hallap, P Padrik, JM Morrell - Microorganisms, 2021 - mdpi.com
Reports on the use of 16S sequencing for the identification of bacteria in healthy animals
are lacking. Bacterial contamination of bull semen can have a negative effect on the sperm …

[HTML][HTML] Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia

K Innos, P Padrik, V Valvere, E Eelma, R Kütner… - BMC Public Health, 2013 - Springer
Background Survival from breast cancer remains lower in Estonia than in most other European
countries. More advanced stage and larger tumors that have impact on survival may be a …

[HTML][HTML] Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification

…, M Palover, T Esko, A Metspalu, N Tõnisson, P Padrik… - BMC cancer, 2019 - Springer
Background Published genetic risk scores for breast cancer (BC) so far have been based on
a relatively small number of markers and are not necessarily using the full potential of large-…

[HTML][HTML] Sex differences in cancer survival in Estonia: a population-based study

K Innos, P Padrik, V Valvere, T Aareleid - Bmc Cancer, 2015 - Springer
Background In Estonia, women have much longer life expectancy than men. The aim of this
study was to examine sex differences in cancer survival in Estonia and to explore the role of …

Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants

…, T Nikopensius, T Esko, A Metspalu, P Padrik… - European Journal of …, 2021 - nature.com
Genotype-first approach allows to systematically identify carriers of pathogenic variants in
BRCA1/2 genes conferring a high risk of familial breast and ovarian cancer. Participants of the …

Bovine sperm plasma membrane proteomics through biotinylation and subcellular enrichment

…, AV Mikelsaar, T Hallap, P Padrik… - …, 2015 - Wiley Online Library
A significant proportion of mammalian fertilization is mediated through the proteomic composition
of the sperm surface. These protein constituents can present as biomarkers to control …

Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study

P Padrik, A Valter, E Valter, A Baburin, K Innos - Acta Oncologica, 2017 - Taylor & Francis
Background: Previous studies have shown an increase in the incidence of cutaneous
melanoma (CM) in Estonia, but also poor survival in international comparisons, with a significant …

The effects of ovarian function on estrus synchronization with PGF in dairy cows

…, T Kaart, M Aidnik, M Jalakas, L Majas, P Padrik - Theriogenology, 2006 - Elsevier
Milk progesterone concentration (P4), milk yield, milk composition, ovarian structures and
pregnancy status were studied in 108 cows treated with two doses of PGF 14 days apart and …

Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region

…, J Mardiak, M Mego, P Padrik… - Expert opinion on …, 2012 - Taylor & Francis
Full article: Optimizing treatment for patients with metastatic renal cell carcinoma in the central
and Eastern European region Skip to Main Content Taylor and Francis Online homepage …